Brief: Acrux Ltd Says US FDA Accepted Co's Application For Generic Version Of Nitroglycerin Ointment For Review
03/07/2023 23:45
July 4 (Reuters) - Acrux Ltd ACR.AX :
* US FOOD AND DRUG ADMINISTRATION ACCEPTED ACRUX'S
APPLICATION FOR
A GENERIC VERSION OF NITROGLYCERIN OINTMENT, 0.4% FOR REVIEW
Source text for Eikon: ID:nASX4St9k3
Further company coverage: ACR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acrux
See all newsBrief: Acrux Licenses Lenzetto For Australian Market For A$5.4 Million
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Acrux Says Capital Gains Tax Exemptions Remain In Place For Acrux
Australia's Acrux jumps on placement to fund female testosterone program
Brief: Acrux Raises A$1.6 Mln Via At 0.95 AU Cents Per Share